Literature DB >> 23794431

[Current Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for therapeutic intravitreal application of Ocriplasmin (JETREA ®) in ophthalmology (May 2013)].

K-U Bartz-Schmidt, B Bertram, N Bornfeld, M Bresgen, N Eter, N Feltgen, W Friedrichs, H Heimann, H Helbig, H Hoerauf, F G Holz, A Kampik, K Lemmen, A Lommatzsch, D Pauleikhoff, J Roider.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23794431     DOI： 10.1055/s-0032-1328668

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN： 0023-2165            Impact factor:   0.700


× No keyword cloud information.
  6 in total

1.  [Ocriplasmin as a treatment option for symptomatic vitreomacular traction with and without macular hole. First clinical experiences].

Authors:  M Maier; S Abraham; C Frank; N Feucht; C P Lohmann
Journal:  Ophthalmologe       Date:  2015-12       Impact factor: 1.059

Review 2.  [Statement of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on the development, diagnostics and treatment of epiretinal gliosis : Status October 2020].

Authors: 
Journal:  Ophthalmologe       Date:  2021-02       Impact factor: 1.059

Review 3.  [Clinicopathological correlations at the vitreoretinal interface].

Authors:  R G Schumann; A Gandorfer; A Kampik; C Haritoglou
Journal:  Ophthalmologe       Date:  2015-01       Impact factor: 1.059

Review 4.  [Watchful waiting as a therapeutic principle for diseases of the vitreoretinal interface].

Authors:  H Hoerauf; B Kirchhof
Journal:  Ophthalmologe       Date:  2017-11       Impact factor: 1.059

5.  Ocriplasmin treatment for vitreomacular traction in real life: can the indication spectrum be expanded?

Authors:  Kleanthis Manousaridis; Silvia Peter-Reichart; Stefan Mennel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-05       Impact factor: 3.117

6.  Early vitreomacular separation with delayed macular hole closure after ocriplasmin treatment.

Authors:  I-Chia Liang; Kai Wang; Hsiang-Wen Chien; Szu-Yuan Lin
Journal:  Indian J Ophthalmol       Date:  2016-03       Impact factor: 1.848
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.